(Reuters) – Generic drugmaker Actavis Plc said on Tuesday it would buy Forest Laboratories Inc for about $25 billion in cash and stock, giving it a major focus on higher-margin, branded treatments for Alzheimer’s, hypertension and other disorders.
Reuters: Business News article archive.
Comments are closed.
Visiting France? Get the best Paris deals at LinkParis.com before your trip.
Arrange a visit to see the D-Day landing beaches in Normandy, the castles of the Loire Valley, a Mont St. Michel tour, Paris Day Trips and more!
Get your NewsFlares.com now!
Email corrections to:
Send news tips to:
Write for us: